ArticleArchiv der Pharmazie2025

Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells.

Bayan Zoatier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.